Morgan Stanley raised the firm’s price target on Penumbra (PEN) to $240 from $210 and keeps an Equal Weight rating on the shares. The firm views Penumbra as having a “solid product portfolio,” but sees a lack of upside to Street consensus, the analyst tells investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra price target raised to $270 from $232 at BTIG
- Penumbra price target raised to $250 from $235 at Piper Sandler
- Penumbra’s CAVT technology shows benefits in pulmonary embolism
- Penumbra price target raised to $232 from $222 at RBC Capital
- Penumbra price target raised to $235 from $225 at Piper Sandler